About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT07495683

Personalizing Psychosocial Intervention for Children With Disruptive Behaviour

This study will develop and test whether personalized profiles of children with Disruptive Behaviour Disorder (DBD) and their parents based on important psychological, emotional, and neuropsychologica...

Lead sponsor: Centre for Addiction and Mental Health•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Centre for Addiction and Mental Health

To accomplish these goals, the investigators will collect psychological, emotional, and neuropsychological measures before and following cognitive behavioural therapy (CBT) for both children and parents. The investigators will use statistical modeling to determine profiles of parents of children and children aged 6-12 years with DBD based on key domains of mental health, emotion regulation, cognition, and parent-child behaviour, and observe whether these profiles allow the study team to predict which sub-groups of parents and children are most and least likely to benefit from child CBT and Behavioural Parent Training (BPT).

Age

6 - 12 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis of Oppositional Defiant Disorder (ODD), Conduct Disorder (CD) or Attention Deficit Hyperactivity Disorder (ADHD) determined by the supervising Clinical Psychologist based on DSM-5 diagnostic criteria on the C-DISC; and/or clinically at risk symptoms on the Child Behavior Checklist/Teacher Report Form (t score \> 60)
•Clinically severe impairment in social, family, peer functioning demonstrated by the parent- and teacher-completed Impairment Rating Scale (IRS) or the virtually administered Columbia Impairment Scale (CIS)
•No evidence of Autism Spectrum Disorder (based on parent and teacher report) or Intellectual Disability (based on the Kaufman Brief Intelligence Task-II OR school reports or psychoeducational assessments).

Exclusion Criteria

•Presence of Autism or Intellectual Disability
•Evidence of cognitive delays or an intellectual disability (based on the Kaufman Brief Intelligence Test-2 (KBIT-2), verbal and/or IQ composite standard score below 80 or collateral information)
•Child behaviour or emotional functioning that make group participation not possible
•Child preference for individual treatment.
•Parent behaviour or emotional functioning that make group participation not possible
•Parent preference for individual treatment.

Related studies

Characterization of Social Cognition Profiles in Children and Adolescents With Neurodevelopmental Disorders: a Clinical Study Using a Multidimensional Battery

NCT07439276 · Neurodevelopmental Disorders, Autism Spectrum Disorder, and more

Developing Brain, Impulsivity and Compulsivity

NCT04631042 · Typical Development, Obsessive Compulsive Disorder, and more

Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD

NCT06810180 · Attention Deficit Hyperactivity Disorder (ADHD), Sleep, and more

L-theanine and Paraxanthine for Cognitive Improvement in Adults With ADHD and ASD

NCT07189442 · Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD)

ADHD PreSMA Response Inhibition Therapy

NCT06325813 · Attention Deficit Hyperactivity Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 27, 2026Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment600

Start dateSep 2016

Last updatedMar 27, 2026

Condition

Behavioural Disorder Disruptive Behavior Disorder Attention Deficit Hyperactivity Disorder Conduct Disorder Oppositional Defiant Disorder+1 more

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 27, 2026Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions